Navigation Links
Smoking Ban To Be Soon Implemented In South East Asian Bars

said a spokeswoman for Singapore's Health Promotion Board.

Singapore smokers made up only 12.6 percent of the population in 2004, one of the lowest rates in the world.

In Malaysia, the health ministry recently announced that discotheques, bars and outdoor recreation parks would soon be designated non-smoking areas.

The ministry plans to hike tobacco taxes by another 13 percent this year. In 2004, the government launched a $27-million, five-year anti-smoking drive dubbed 'Tak Nak' or 'Don't Want It', but it is facing tough resistance from Malaysian puffers, who account for five million of the country's 23 million people.

'The efforts against smoking are not achieving much,' admitted Mohamed Idris of the Consumers Association in Penang. 'The smoking habit is being successfully promoted and new smokers are still being recruited every day.'

Indonesia, where 62 percent of adult men are smokers, ranks fifth among the world's leading tobacco consumers. The government's anti-smoking efforts have run into serious opposition.

A ban on smoking in all public places in capital Jakarta was announced last year but went into force only this month, giving puffers a year-long grace period to adjust to the city ordinance that sets a $5,000 fine and six-month jail penalty for violations.

In the Philippines, tobacco lobbyists are also a problem.

'There are several lobbying efforts from tobacco companies and business establishments, who prefer not to have anti-smoking ordinances because these affect their business,' said a Manila-based World Health Organisation (WHO) official who preferred to remain anonymous.


'"/>




Page: 1 2

Related medicine news :

1. New hope on the Horizon for People Wishing to Quit Smoking
2. Cancers of Colon & Rectum linked to Cigarette Smoking
3. Smoking a greater risk than HIV? Yes say health experts!!!!
4. Kick Smoking with Nicotine Drink
5. Smoking spreads Cancer
6. Prescription Drug - Helps People Stop Smoking
7. Quit Smoking
8. Smoking can depreciate intellegence
9. Smoking Delays Pregnancy
10. Smoking Linked To Low Infant Birth Weight
11. GlaxoSmithKline To Cultivate Non-Smoking Environment
Post Your Comments:
(Date:5/16/2008)...USTON - Gefitinib, the once-promising drug formerl...cer, also known as Iressa, enhanced the effectiven...fic types of metastatic breast cancer, according t...The University of Texas M. D. Anderson Cancer Cent...t the first positive study for Iressa in breast ca...
(Date:5/16/2008)...TON, May 16 /PRNewswire-USNewswire/ -- Behavioral ...ponding to the needs of the millions,of Americans ...ce use,conditions each year, according to the late...Psychiatric Health Systems (NAPHS) released today....nct views of behavioral,healthcare delivery. One c...
(Date:5/16/2008)...y announces appointment of Nomura Code Securities ... sole broker, NEW YORK, May 16 /PRNewswire-FirstC...l Investments, Inc. (Amex: MGT ) (the "Company"),...uter-Aided Detection (CAD) and,image analysis soft...nosis,of disease, today announced the appointment ...
(Date:5/16/2008)...T, Conn., May 16 /PRNewswire/ -- Tao Formulations ...opause Relief Formula, at the Internal,Medicine 20... product is,the culmination of years of research t...gen-free) alternative for relieving menopausal sym... board certified obstetrician,and gynecologist, fo...
Breaking Medicine News(10 mins):Health News:Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy 2Health News:Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy 3Health News:New NAPHS Annual Survey Tracks Behavioral Treatment Trends 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 3Health News:Tao Formulations Announces the Official Launch of Tao Harmony - Menopause Relief Formula 2
...(Jawaharlal Institute of Postgraduate Medical Coll...day //long strike to protest against the governmen...her educational institutes. A spokesman of the As...t they had submitted a memo to the government to h...
...triking medicos to immediately call off their 20-d...and resume work within three days. The court - whi... also warned that strong action will be taken if i...ed. "We direct that all strikes, protests and dem...
...eat diabetic nerve damage has shown promising resu...s// of the University of Manchester, when injected...ular gene responsible to prevent nerve damage in h...he positive preclinical results – reported in the ...
...Centrally administered Jawaharlal Nehru Institute ...IPMER) // in Pondicherry today began a 48-hour lon...te educational institutions. A batch of resident ...ast inside the campus urging the Centre to review ...
Other Medicine News:Health News:New Gene Therapy Treats Diabetic Neuropathy 2
(Date:5/15/2008)...ay 15 /- Eisai Corporation of North,A...al data abstracts about,compounds in the company,s...cal oncology research have been accepted for prese... Society of Clinical Oncology (ASCO),taking place...variety of abstracts on Eisai marketed products an...
(Date:5/15/2008)...ical Data from Prostate, Colorectal and Ovarian ...to Hold Investor Event on Sun., June 1 with Oncolo... /- Poniard,Pharmaceuticals...ny focused,on oncology, today announced that the C...s of picoplatin, in various tumor types and combin...
(Date:5/15/2008)...5 /- Schering-Plough,Corpor...ence and treatment of,chronic hepatitis C virus (H...ral clinical studies with PEGINTRON(TM) (peginterf...ination therapy, as well as boceprevir, the,compan...ill be presented at,the 39th annual Digestive Dise...
(Date:5/15/2008)...ULOUSE, France, May 15 /- Cerenis,The...tical company,developing HDL-related compounds for...eases, today announced that it has completed a Pha...y,s lead product candidates.,CER-002 is a peroxiso...ecific agonist in development for the treatment of...
Breaking Medicine Technology:Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 2Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 3Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 4Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 5Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 6Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 7Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 8Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 2Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 3Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 4Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2Kaiser Permanente Study Shows Newer Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk 2671 1Kaiser Permanente Study Shows Newer Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk 2671 2Kaiser Permanente Study Shows Newer Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk 2671 3Kaiser Permanente Study Shows Newer Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk 2671 4Kaiser Permanente study shows link between caffeine and miscarriage 9813 1Kaiser Permanente study shows link between caffeine and miscarriage 9813 2Kaiser Permanente study shows link between caffeine and miscarriage 9813 3Pros cons of drug proven to prevent prostate cancer should be considered researchers recommend 9810 1Pros cons of drug proven to prevent prostate cancer should be considered researchers recommend 9810 2NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 1NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 2NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 3NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 4NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 5
...gned to provide functional management of stress fr...able fractures of the lower leg.,The Leg Brace fea...patented Duplex™ aircell system. This exclus...ng aircells, distal and proximal, that provide sup...
...s available with optional hot and cold therapy Gel...roviding cold therapy to reduce swelling and /or h...covery.,To order hot and cold therapy gel pad, pla...o fit., ,Our Patented Formfit 3-dimensional moldi...
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
FREEDOM® Memory Thumb Spica lets you make a custom splint in minutes. Immerese in 160 F water until pliable, and remove. Amazingly, it maintains its shape and is ready to be precisely, profession
Medicine Products: